<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6947-1-2.anc" start="12815" end="12822" sStart="-1" offset="0" sid="null" wn="2147483645" wnkey="null" annotator="tofox" text="In describing NNT, respondents preferred the &lt;b&gt;written&lt;/b&gt; explanation which rescaled data from &quot;1-in x&quot; to &quot;x out of 100&quot; (Table 3d)." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6947-1-2.anc" start="10011" end="10019" sStart="null" offset="39" sid="r11.refer.v.0310" wn="7" wnkey="refer%2:32:04::" annotator="vebatchelder" text="The alternative explanation (referred to as &quot;x out of 100&quot;) was worded &quot;If 100 women just like you were to take lifelong HRT, treatment would prevent 12 of them from developing heart disease and 11 of them from developing a hip fracture." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6947-1-2.anc" start="9535" end="9543" sStart="null" offset="33" sid="r11.refer.v.0455" wn="7" wnkey="refer%2:32:04::" annotator="anfahmy" text="The first explanation (referred to as &quot;1 in x&quot;) was worded &quot;If 8 women just like you took lifelong HRT, it would prevent one of the 8 from having heart disease." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6947-1-2.anc" start="14528" end="14532" sStart="null" offset="228" sid="r9.full.j.0346" wn="2" wnkey="full%5:00:01:whole:00" annotator="anfahmy" text="Analyzing comprehension of each format at this stage was not feasible considering the additional time burden it would have imposed on our study participants (focus group sessions lasted a full 2 hours)." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6947-1-2.anc" start="15345" end="15351" sStart="null" offset="129" sid="r10.common.j.0269" wn="4" wnkey="common%5:00:00:familiar:02" annotator="veweser" text="Not all possible graph types were presented to study participants, although we attempted to include the most common graph types from the scientific and popular press." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7293" end="7299" sStart="null" offset="0" sid="null" wn="4" wnkey="chance%1:07:00::" annotator="veweser" text="The survival curve was atypical in that its y-axis presented a patient's &lt;b&gt;chance&lt;/b&gt; of not developing a disease instead of the more standard &quot;&lt;b&gt;chance&lt;/b&gt; of survival&quot;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7293" end="7299" sStart="null" offset="0" sid="null" wn="4" wnkey="chance%1:07:00::" annotator="tofox" text="The survival curve was atypical in that its y-axis presented a patient's &lt;b&gt;chance&lt;/b&gt; of not developing a disease instead of the more standard &quot;&lt;b&gt;chance&lt;/b&gt; of survival&quot;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7218" end="7224" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="tofox" text="The survival curve was atypical in that its y-axis presented a patient's &lt;b&gt;chance&lt;/b&gt; of not developing a disease instead of the more standard &quot;&lt;b&gt;chance&lt;/b&gt; of survival&quot;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7625" end="7631" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="tofox" text="This modification was made to keep the data presented consistent with data presented in the other graphical formats since survival was not presented in the other graphs (the &lt;b&gt;chance&lt;/b&gt; of not developing a disease is the closest equivalent to survival, which is the &lt;b&gt;chance&lt;/b&gt; of not dying)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7518" end="7524" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="tofox" text="This modification was made to keep the data presented consistent with data presented in the other graphical formats since survival was not presented in the other graphs (the &lt;b&gt;chance&lt;/b&gt; of not developing a disease is the closest equivalent to survival, which is the &lt;b&gt;chance&lt;/b&gt; of not dying)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7218" end="7224" sStart="null" offset="0" sid="null" wn="4" wnkey="chance%1:07:00::" annotator="comcgeetubb" text="The survival curve was atypical in that its y-axis presented a patient's &lt;b&gt;chance&lt;/b&gt; of not developing a disease instead of the more standard &quot;&lt;b&gt;chance&lt;/b&gt; of survival&quot;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7625" end="7631" sStart="null" offset="0" sid="null" wn="4" wnkey="chance%1:07:00::" annotator="comcgeetubb" text="This modification was made to keep the data presented consistent with data presented in the other graphical formats since survival was not presented in the other graphs (the &lt;b&gt;chance&lt;/b&gt; of not developing a disease is the closest equivalent to survival, which is the &lt;b&gt;chance&lt;/b&gt; of not dying)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7518" end="7524" sStart="null" offset="0" sid="null" wn="4" wnkey="chance%1:07:00::" annotator="comcgeetubb" text="This modification was made to keep the data presented consistent with data presented in the other graphical formats since survival was not presented in the other graphs (the &lt;b&gt;chance&lt;/b&gt; of not developing a disease is the closest equivalent to survival, which is the &lt;b&gt;chance&lt;/b&gt; of not dying)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7218" end="7224" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="chisom" text="The survival curve was atypical in that its y-axis presented a patient's &lt;b&gt;chance&lt;/b&gt; of not developing a disease instead of the more standard &quot;&lt;b&gt;chance&lt;/b&gt; of survival&quot;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7625" end="7631" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="chisom" text="This modification was made to keep the data presented consistent with data presented in the other graphical formats since survival was not presented in the other graphs (the &lt;b&gt;chance&lt;/b&gt; of not developing a disease is the closest equivalent to survival, which is the &lt;b&gt;chance&lt;/b&gt; of not dying)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7518" end="7524" sStart="null" offset="0" sid="null" wn="" wnkey="null" annotator="chisom" text="This modification was made to keep the data presented consistent with data presented in the other graphical formats since survival was not presented in the other graphs (the &lt;b&gt;chance&lt;/b&gt; of not developing a disease is the closest equivalent to survival, which is the &lt;b&gt;chance&lt;/b&gt; of not dying)." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6947-1-2.anc" start="2740" end="2748" sStart="null" offset="125" sid="r11.benefit.n.0695" wn="2" wnkey="benefit%1:07:00::" annotator="anfahmy" text="In addition to consideration of which metric is used to describe risks, the time horizon over which risks or benefits occur may affect risk interpretation." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6947-1-2.anc" start="2052" end="2060" sStart="null" offset="12" sid="r11.benefit.n.0515" wn="2" wnkey="benefit%1:07:00::" annotator="anfahmy" text="Framing the benefits of treatment in relative rather than absolute terms may emphasize the short-term benefits of a treatment [ 6 9 ] . Conversely, framing the risks of treatment in relative rather than absolute terms may emphasize its risks [ 10 ] . Comparing relative and absolute risk reduction and NNT as methods to inform patients about preventive therapies, Hux et al illustrated that the metric used to present data can affect a patient's perception of a therapy's effectiveness [ 11 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7912" end="7917" sStart="null" offset="18" sid="r8.ask.v.0805" wn="3" wnkey="ask%2:32:05::" annotator="veweser" text="Participants were asked to rate how much they liked each graph on a likert scale of 1 to 5, with 1 corresponding to &quot;not at all&quot; and 5 corresponding to &quot;extremely&quot;, and then to rank order the graphs according to preference." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6947-1-2.anc" start="7912" end="7917" sStart="null" offset="18" sid="r8.ask.v.0805" wn="" wnkey="null" annotator="ksuderman" text="Participants were asked to rate how much they liked each graph on a likert scale of 1 to 5, with 1 corresponding to &quot;not at all&quot; and 5 corresponding to &quot;extremely&quot;, and then to rank order the graphs according to preference." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6947-1-2.anc" start="637" end="642" sStart="null" offset="175" sid="r8.ask.v.0608" wn="1" wnkey="ask%2:32:01::" annotator="cgozo" text="A recent study examining the effect of drug advertisements on consumer behavior found that 19% of study participants asked for a prescription, and 35% asked a physician for information about a drug after seeing a drug advertisement [ 1 ] . In order for patients to be effective participants in the decision making process, they need information on the effects of treatment on their health risks that they can use to make health care decisions." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6947-1-2.anc" start="8233" end="8238" sStart="null" offset="23" sid="r8.ask.v.0320" wn="1" wnkey="ask%2:32:01::" annotator="cgozo" text="Participants were also asked to rank order their preferences for risk estimates over 10-year, 20-year, or lifetime horizons, presented using bar graphs predicting a woman's risk for developing heart disease, hip fracture and breast cancer." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6947-1-2.anc" start="8650" end="8656" sStart="null" offset="104" sid="r8.ask.v.0643" wn="1" wnkey="ask%2:32:01::" annotator="brubin" text="Participants' preferences for risk displays about multiple clinical outcomes were elicited by asking participants to choose between 2 sets of 3 graphs." />
    <s path="[OANC]/data/written_2/technical/biomed/1472-6947-1-2.anc" start="3950" end="3956" sStart="null" offset="430" sid="r9.appear.v.0470" wn="1" wnkey="appear%2:39:00::" annotator="anfahmy" text="For example, the decision of whether or not to use hormone replacement therapy (HRT) after menopause involves weighing the benefits of treatment (immediate symptom relief, [ 12 ] decreased future risk of hip fracture [ 13 ] and possible decreased risk of coronary heart disease [ 14 15 ] ) against its risks (increased future risk of breast cancer [ 15 ] ). Framing effects appear to be smaller when both the beneficial and harmful effects of a treatment are included, [ 16 ] but little information is available to guide clinicians about how to explain complex risk information to their patients." />
  </sentences>
</list>